Literature DB >> 28202215

Erratum to 'Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy' [Oral Oncol. 61 (2016) 166-176].

R Bryan Bell1, Michael J Gough2, Steven K Seung3, Zeljka Jutric2, Andrew D Weinberg2, Bernard A Fox2, Marka R Crittenden3, Rom S Leidner4, Brendan Curti2.   

Abstract

Entities:  

Year:  2017        PMID： 28202215     DOI： 10.1016/j.oraloncology.2017.02.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN： 1368-8375            Impact factor:   5.337


× No keyword cloud information.
  2 in total

1.  Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma.

Authors:  Rom Leidner; Marka Crittenden; Kristina Young; Hong Xiao; Yaping Wu; Marcus A Couey; Ashish A Patel; Allen C Cheng; Amber L Watters; Carlo Bifulco; George Morris; Lessli Rushforth; Shorin Nemeth; Walter J Urba; Michael Gough; R Bryan Bell
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

2.  Implantable biomaterials to provide local immunotherapy following surgical resection.

Authors:  Michael J Gough; Jason R Baird; R Bryan Bell
Journal:  Oncotarget       Date:  2018-12-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.